From USD 523.9M to USD 869.8M: Europe Viscosupplementation Market Set for 5.2% CAGR Growth
The Europe viscosupplementation market has been steadily gaining momentum as a preferred treatment for osteoarthritis and other joint-related ailments. Viscosupplementation involves the injection of hyaluronic acid or similar substances directly into the joint space to restore the natural lubrication, thereby alleviating pain and improving mobility. As the aging population in Europe continues to grow, the demand for effective, minimally invasive treatments for degenerative joint conditions has significantly increased. This market reflects the broader shift towards non-surgical interventions that offer patients pain relief and improved joint function without the risks associated with invasive procedures. The Europe viscosupplementation market is expected to be reach USD 523.9 million in 2025 and is likely to expand up to approximately USD 869.8 million by the end of 2035. The sales are believed to rise with a CAGR of 5.2% during the period of 2025 to 2035. Healthcare provider...